Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Fresenius Medical Care AG (FMS) Tax Provisions: 2009-2024

Historic Tax Provisions for Fresenius Medical Care AG (FMS) over the last 16 years, with FY2024 value amounting to $342.1 million.

  • Fresenius Medical Care AG's Tax Provisions fell 3128.44% to $87.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $305.6 million, marking a year-over-year decrease of 1753.83%. This contributed to the annual value of $342.1 million for FY2024, which is 578.21% up from last year.
  • As of FY2024, Fresenius Medical Care AG's Tax Provisions stood at $342.1 million, which was up 578.21% from $323.4 million recorded in FY2023.
  • In the past 5 years, Fresenius Medical Care AG's Tax Provisions registered a high of $571.5 million during FY2020, and its lowest value of $323.4 million during FY2023.
  • Its 5-year average for Tax Provisions is $396.6 million, with a median of $342.5 million in 2022.
  • Its Tax Provisions has fluctuated over the past 5 years, first soared by 2706.78% in 2020, then crashed by 2937.64% in 2021.
  • Over the past 5 years, Fresenius Medical Care AG's Tax Provisions (Annual) stood at $571.5 million in 2020, then dropped by 29.38% to $403.6 million in 2021, then dropped by 15.15% to $342.5 million in 2022, then fell by 5.58% to $323.4 million in 2023, then increased by 5.78% to $342.1 million in 2024.
  • Its Tax Provisions was $342.1 million in FY2024, compared to $323.4 million in FY2023 and $342.5 million in FY2022.